Regeneron Pharmaceuticals, Inc...
NASDAQ: REGN
$574.61
-$8.52 (-1.5%)
Closing price July 30, 2021
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.
1 month ago
Last Updated: 1 month ago
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
6 months ago
Last Updated: 5 months ago
Monday's top analyst upgrades and downgrades included American Eagle Outfitters, Baidu, GameStop, Halliburton, Mosaic, Regeneron Pharmaceuticals, Salesforce.com, Take-Two Interactive Software and...
6 months ago
Last Updated: 1 month ago
Wednesday's top analyst upgrades and downgrades included AbbVie, Albertsons, DuPont, Exxon Mobil, Home Depot, KB Home, Mastercard, Palantir and Twitter.
6 months ago
Last Updated: 6 months ago
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
7 months ago
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
7 months ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
8 months ago
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
8 months ago
Regeneron Pharma reported its third-quarter financial results before the markets opened on Thursday.
8 months ago
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including General Motors, T-Mobile and Uber.
8 months ago
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe, more...
9 months ago
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
9 months ago
Here are 13 other companies that should seriously entertain splitting their stocks. Splits are of course a gimmick, but the stock market usually rewards companies for splitting their stocks.
9 months ago
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
9 months ago
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
9 months ago